This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

OnCure Holdings, Inc. And Certain Affiliates File Petitions Under Chapter 11

ENGLEWOOD, Colo., June 14, 2013 /PRNewswire/ -- OnCure Holdings, Inc. and certain of its affiliates, leading providers of management services and facilities to oncology physician groups throughout the country, filed voluntary petitions to commence proceedings under Chapter 11 of the United States Bankruptcy Code in an effort to restructure their finances.  The petitions were filed in the United States Bankruptcy Court for the District of Delaware.

Prior to filing, OnCure, in consultation with an ad hoc group of secured noteholders, engaged in an extensive campaign to market the company's assets to potential financial and strategic buyers, resulting in an agreement in principle regarding a proposed acquisition with a third-party purchaser for aggregate consideration of approximately $125 million (and with reimbursement of certain expenses, of approximately $126.5 million).  The transaction remains subject to the negotiation and execution of definitive documentation by the parties. 

OnCure's legal advisors in connection with its restructuring are Latham & Watkins LLP and Richards, Layton & Finger, P.A.  Financial advisory services are being provided by Jefferies LLC. Match Point Partners LLC is providing management services to OnCure.

For more information on OnCure, please visit www.oncure.com .  For more information on OnCure's bankruptcy case, please visit www.kccllc.net/oncure , email OnCureInfo@kccllc.com , or call the case-dedicated toll-free phone number at (877) 634-7166.

SOURCE OnCure Holdings, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs